<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Treatment of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>-related malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (ARL) remains a therapeutic challenge </plain></SENT>
<SENT sid="1" pm="."><plain>There are concerns not only about infectious and haematological complications in HIV-infected patients during intensive chemotherapy, but also about potential interactions between chemotherapy and highly active antiretroviral therapy (HAART) </plain></SENT>
<SENT sid="2" pm="."><plain>Current data on patients treated concomitantly with intensive chemotherapy and HAART are limited, and no data exist on patients with ARL suffering from active <z:e sem="disease" ids="C0029118" disease_type="Disease or Syndrome" abbrv="">opportunistic infections</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We report the case of a 38-year-old man with advanced HIV-1 infection, <z:e sem="disease" ids="C0041327" disease_type="Disease or Syndrome" abbrv="">pulmonary tuberculosis</z:e> and Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Intensive chemotherapy was administered in parallel with tuberculostatic therapy and HAART </plain></SENT>
<SENT sid="5" pm="."><plain>Six months later, the patient achieved not only a complete remission of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and sustained <z:mp ids='MP_0001799'>viral</z:mp> suppression, but also a full recovery from <z:e sem="disease" ids="C0041296" disease_type="Disease or Syndrome" abbrv="tb|tbc">tuberculosis</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>This case report provides some useful observations on the successful application of intensive chemotherapy in addition to tuberculostatic therapy and HAART in HIV-infected patients </plain></SENT>
</text></document>